Vers une nouvelle classification des diabètes

Precision medicine makes it possible to classify patients into groups on the basis of molecular and genetic biomarkers, as well as clinical characteristics, in order to optimize therapeutic response. For example, several types of type 2 diabetes seem to coexist with classic insulin-dependent, autoimmune type 1 diabetes : diabetes with insulinopenia (generally severe), diabetes linked to aging or obesity (less severe), and diabetes with insulin resistance, whose patients will be those with the most numerous complications, notably macrovascular. In this article, we examine the possibilities offered by this new classification of diabetes with a view to personalized medicine.